Whether hypoxanthine production from inosine confers higher protection from T2D in individuals carrying these polymorphisms, by inhibiting the activation of poly(ADP-ribose) polymerase39 and thus increasing TCF7L2-mediated GLP-1 production and activity40, needs to be further explored. This evidence concerns the gene GCG and type 2 diabetes mellitus.